On January 18, guichuangtong bridge, a Hong Kong listed company of Chinese neurological and peripheral vascular intervention medical devices, announced that the company will invest in Weiya medical as a strategic investor, help the R & D process of the latter and promote the implementation of vascular intervention Siasun Robot&Automation Co.Ltd(300024) in clinical application.
Weiya medical is a Innovation Medical Management Co.Ltd(002173) instrument enterprise in China, which is committed to developing Siasun Robot&Automation Co.Ltd(300024) comprehensive solutions for interventional surgery of coronary artery, nerve and peripheral blood vessels. Its new and original delivery technology will improve the efficiency, accuracy and stability of vascular interventional surgery, fully meet the needs of doctors for interventional surgery, and the practicability of the product has been recognized by many top experts in China.
Guichuangtong bridge is a leader in the market of neurological and peripheral vascular interventional medical devices in China. It is a top interventional medical device company developing minimally invasive vascular interventional medical devices. The fields of product treatment include acute ischemic stroke, intracranial aneurysms, carotid stenosis, peripheral arterial and venous diseases and dialysis related diseases.
The investment in Weiya medical, GUI chuangtong bridge said, is to promote the standardized, accurate and intelligent development of vascular interventional therapy, and improve the company’s layout of Pan vascular interventional therapy solutions. As a strategic investor, guichuangtong bridge will use its own resources and expertise to help Weiya medical research and development, accelerate the commercialization process, and jointly promote the implementation of vascular intervention Siasun Robot&Automation Co.Ltd(300024) in clinical application. At the same time, guichuangtong bridge will give priority to the exclusive agency sales right of products developed by Weiya Medical Institute in specific regions.
